184 related articles for article (PubMed ID: 9354406)
1. Introduction: changing trends in antiarrhythmic therapy: worldwide experience with class III agents.
Singh BN; Breithardt G
Am J Cardiol; 1997 Oct; 80(8A):1G-3G. PubMed ID: 9354406
[No Abstract] [Full Text] [Related]
2. Ventricular arrhythmias. When should they be suppressed?
Marcus FI
Postgrad Med; 1991 Aug; 90(2):62-4, 67-9. PubMed ID: 1862051
[TBL] [Abstract][Full Text] [Related]
3. Do we need new antiarrhythmic compounds in the era of implantable cardiac devices and percutaneous ablation?
Christ T; Ravens U
Cardiovasc Res; 2005 Dec; 68(3):341-3. PubMed ID: 16256089
[No Abstract] [Full Text] [Related]
4. Implications of the ESVEM trial for use of antiarrhythmic drugs that prolong cardiac repolarization.
Mason JW
Am J Cardiol; 1993 Nov; 72(16):59F-61F. PubMed ID: 8237831
[TBL] [Abstract][Full Text] [Related]
5. [Ideal future antiarrhythmic therapy: a view from Japanese physicians].
Yamashita T
Nihon Yakurigaku Zasshi; 2008 Jun; 131(6):457-61. PubMed ID: 18552449
[No Abstract] [Full Text] [Related]
6. Drugs for cardiac arrhythmias.
Treat Guidel Med Lett; 2004 Nov; 2(27):75-82. PubMed ID: 15529117
[No Abstract] [Full Text] [Related]
7. The rapidly changing management of cardiac arrhythmias.
Hammill SC; Hubmayr RD
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1070-3. PubMed ID: 10764291
[No Abstract] [Full Text] [Related]
8. [Clinical countermeasures to arrhythmias].
Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Feb; 21(1):5-14. PubMed ID: 7693410
[No Abstract] [Full Text] [Related]
9. Cardiac arrhythmias--trials and tribulations.
Camm AJ
Lancet; 2012 Oct; 380(9852):1448-51. PubMed ID: 23101702
[No Abstract] [Full Text] [Related]
10. Evaluation and management of cardiac arrhythmias in the elderly.
Tresch DD
Med Clin North Am; 2001 Mar; 85(2):527-50, xii. PubMed ID: 11233958
[TBL] [Abstract][Full Text] [Related]
11. Non-classical indications for cardiac resynchronization therapy.
Beinart R; Michaelidis A; Glikson M
Hellenic J Cardiol; 2009; 50(3):208-15. PubMed ID: 19465362
[No Abstract] [Full Text] [Related]
12. Pharmacologic therapy of arrhythmias.
Naccarelli GV; Rinkenberger RL; Dougherty AH; Berns E; Crandell JR
Hosp Pract (Off Ed); 1988 Oct; 23(10):183-7, 190-2, 194-5 passim. PubMed ID: 3139691
[No Abstract] [Full Text] [Related]
13. Arrhythmias in 2015: Advances in drug, ablation, and device therapy for cardiac arrhythmias.
Macle L; Nattel S
Nat Rev Cardiol; 2016 Feb; 13(2):67-8. PubMed ID: 26727299
[No Abstract] [Full Text] [Related]
14. Current clinical perspectives on antiarrhythmic drug therapy.
Anderson JL
Fed Proc; 1986 Jul; 45(8):2213-9. PubMed ID: 3720963
[TBL] [Abstract][Full Text] [Related]
15. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
Scholz H
Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
[TBL] [Abstract][Full Text] [Related]
16. The clinical pharmacology of antiarrhythmic drugs.
Adams PC; Campbell RW; Julian DG
Cardiovasc Clin; 1984; 14(3):153-90. PubMed ID: 6722851
[No Abstract] [Full Text] [Related]
17. [Recent trends in anti-arrhythmia therapy].
Ogawa S
Nihon Naika Gakkai Zasshi; 1995 Mar; 84(3):439-41. PubMed ID: 7751785
[No Abstract] [Full Text] [Related]
18. [The working classification of antiarrhythmic drugs based on the pathogenetic approach to treatment of cardiac arrhythmias].
Lipnitskiĭ TN; Kozlovskiĭ VA
Lik Sprava; 2002; (8):26-30. PubMed ID: 12669534
[TBL] [Abstract][Full Text] [Related]
19. Contemporary management of arrhythmias during pregnancy.
Enriquez AD; Economy KE; Tedrow UB
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):961-7. PubMed ID: 25336366
[No Abstract] [Full Text] [Related]
20. [Effect of a new antiarrhythmic drug, bunaftine, on the bundle of His].
Scibilia G; Bonatti V; Pavarani A; Tagliavini S; Botti G
Cardiol Prat; 1973; 24(1):79-84. PubMed ID: 4575451
[No Abstract] [Full Text] [Related]
[Next] [New Search]
